NDC 67457-266-00 - Levetiracetam

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
67457-266
Requested NDC
67457-266-00
Package NDCs from labels
67457-266-00, 67457-266-10
Manufacturer
Mylan Institutional LLC
Effective date
2024-03-15
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Levetiracetam - Mylan Institutional LLCMylan Institutional LLC2024-03-15HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67457-266-00Levetiracetam100 mL in 1 BAGINJECTION10018
67457-266-10Levetiracetam10 in 1 CARTONINJECTION1018

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67457-266LEVETIRACETAM INJECTION [MYLAN INSTITUTIONAL LLC]18Current NDC, Legacy NDC, 2 package rows20240606_70e52e89-3844-4cd9-a406-b29e9520a12c.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
67457-266-00ML - Milliliter67457-26658c9cdf6-969e-4e8c-8e32-68d85d3a5e4812012-07-24
67457-266-10ML - Milliliter67457-266e1621834-2365-4203-908c-bccbc5e03ef712012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LEVETIRACETAMACTIVE INGREDIENT44YRR34555LEVETIRACETAM INJECTION [MYLAN INSTITUTIONAL LLC]2
LEVETIRACETAMACTIVE MOIETY44YRR34555LEVETIRACETAM INJECTION [MYLAN INSTITUTIONAL LLC]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 61 · 1,205 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Normal SaltSODIUM CHLORIDEGRAXCELL PHARMACEUTICAL, LLCf3f09817-8a38-4aa1-956b-69d9cf6950742026-10-26WarningsExact identifier
unii: 451W47IQ8X
Bacteriostatic WaterWATERHenry Schein, Inc.a833502e-a622-4e81-8c58-cef6ccb6c4c92026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
Levetiracetam LevetiracetamLEVETIRACETAMAtlantic Biologicals Corp.56fed03f-38c3-4273-8fd7-522bc508bf362026-10-23Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
SalineNASALPUBLIX SUPER MARKETS, INC19841567-9511-43d6-ba4e-d1e1bd3481a42026-10-22WarningsExact identifier
unii: 451W47IQ8X
Fendall 1000 Pure FlowPURIFIED WATERProtective Industrial Products, Inc.55a2f4da-bb1e-8ead-e063-6394a90af72e2026-10-21WarningsExact identifier
unii: 059QF0KO0R
LevetiracetamLEVETIRACETAMMajor Pharmaceuticalsc4b27429-50a3-467c-a5ff-7e49a01a10882026-10-20Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
Walgreens Sterile Soothing Eye WashPURIFIED WATERWalgreensa62e3294-abd6-48dc-81b1-62a809bdc9682026-10-19WarningsExact identifier
unii: 059QF0KO0R
LevetiracetamLEVETIRACETAMPD-Rx Pharmaceuticals, Inc.792db8dc-177b-4864-8600-12823819082d2026-10-15Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
LevetiracetamLEVETIRACETAMREMEDYREPACK INC.94d042f7-93b9-43bd-9ace-cfc61903b4d72026-10-14Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
LevetiracetamLEVETIRACETAMREMEDYREPACK INC.74ccc9f1-b957-4b1b-9464-1b5e3318c9162026-10-14Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
Isolyte S pH 7.4SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATEB. Braun Medical Inc.150437b6-320e-4c69-a434-2a26a1f0b2e42026-10-12Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
unii: 4550K0SC9B
Isolyte SSODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDEB. Braun Medical Inc.7e8fe27f-ff82-48c1-9bf6-3c589c8e985d2026-10-12Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
unii: 4550K0SC9B
Sodium ChlorideSODIUM CHLORIDECODAN US CORPORATIONaa06e286-75c6-4d7a-959f-6008d38aa6e52026-10-08Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
LevetiracetamLEVETIRACETAMGranules Pharmaceuticals Inc.b4781ec4-43ad-4052-9a6a-b24fda119b322026-10-08Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
GoLYTELYPOLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDEBraintree Laboratories, Inc.57d22b0b-1ae0-4203-babc-f3bac17bd1c92026-10-08Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
PEG-3350 and ElectrolytesPOLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDEAffordable Pharmaceuticals, LLC448db7a5-1fea-4bf3-b1f5-e9d027a366032026-10-08Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
PEG-3350, sodium chloride, sodium bicarbonate and potassium chloridePOLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDEAffordable Pharmaceuticals, LLC89ca6d56-527a-4be2-baea-531156f0a7be2026-10-08Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
Sodium ChlorideSODIUM CHLORIDENextgen Pharmaceuticals LLC28f79c75-82d2-4912-81fc-a723b5ccf4c12026-10-08Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
Sodium ChlorideSODIUM CHLORIDESOLA Pharmaceuticals, LLC4d0bfd28-460a-48ba-bd17-cf75e56d62f42026-10-08Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X
Sodium ChlorideSODIUM CHLORIDELABORATORIOS GRIFOLS SAeb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf2026-10-08Warnings, Adverse reactionsExact identifier
unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.